{
event: "article_read",
name: `Module 5: The Current and Emerging Management of Autoimmune Type 1 Diabetes`,
author: ``,
tags: ``,
publication_date: ``,
interaction_type: "content"
}
- Resource
- BR1DGE
Module 5: The Current and Emerging Management of Autoimmune Type 1 Diabetes
This module explores current evidence-based management approaches for T1D and examines emerging therapeutic strategies that may modify the course of T1D
Chapter 5.1: Current and Emerging Management Options for Type 1 Diabetes
This chapter will explore current and emerging therapies and the fundamental principles of insulin management
Learning Objectives
- Recognize insulin replacement therapy treats the symptoms of T1D but does not eliminate the burden
- Highlight several investigational immunotherapies in Phase 2 and Phase 3 development have shown the ability to significantly preserve beta-cell function in recent-onset Stage 3 T1D
- Understand how the future of T1D care looks to shift focus from insulin therapy to preserving beta cells
Learning Objectives
- Understand the role of TCOYD in improving outcomes for individuals with T1D
- Explore the evolving role of social media in diabetes education and outreach in the post-COVID era
Congratulations on completing BR1DGE Module 5: The Current and Emerging Management of Autoimmune Type 1 Diabetes!